Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions

@article{Hung2006GeneticST,
  title={Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions},
  author={S. Hung and Wen-Hung Chung and Shiou-Hwa Jee and W. Chen and Y. Chang and W. Lee and S. Hu and Meng-Tse Wu and G. Chen and T. Wong and Pa-Fan Hsiao and Wei-Hsuan Chen and Han-Yu Shih and Wu-Hsiang Fang and C. Wei and Yi-Hui Lou and Yau-Li Huang and J. Lin and Y. Chen},
  journal={Pharmacogenetics and Genomics},
  year={2006},
  volume={16},
  pages={297-306}
}
  • S. Hung, Wen-Hung Chung, +16 authors Y. Chen
  • Published 2006
  • Medicine
  • Pharmacogenetics and Genomics
    • The anticonvulsant carbamazepine (CBZ) frequently causes cutaneous adverse drug reactions (cADRs), including maculopapular eruption (MPE), hypersensitivity syndrome (HSS), Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). We reported that SJS/TEN caused by CBZ is strongly associated with the HLA-B*1502 gene in Han Chinese. Here, we extended our genetic study to different types of CBZ-cADRs (91 patients, including 60 patients with SJS/TEN, 13 patients with hypersensitivity… CONTINUE READING
    View on Wolters Kluwer
    ncbi.nlm.nih.gov
    540 Citations
    Highly Influential Citations
    41
    Background Citations
    144
    Methods Citations
    6
    Results Citations
    35
    540 Citations
    Citation Type

    Citation Type

    Human leukocyte antigen genotypes in carbamazepine‐induced severe cutaneous adverse drug response in Japanese patients
    • 56
    Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China
    • 93
    HLA Genotype and Carbamazepine‐Induced Cutaneous Adverse Drug Reactions: A Systematic Review
    • 118
    A recent update of pharmacogenomics in drug-induced severe skin reactions.
    • 39
    Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
    • 232
    Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    • 51
    Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.
    • 18
    • PDF
    Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.
    • Pei Chen, J. Lin, +30 authors C. Shen
    • Medicine
    • The New England journal of medicine
    • 2011
    • 391
    Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.
    • 56
    Genetic predisposition of life-threatening antiepileptic-induced skin reactions
    • 70

    References

    SHOWING 1-10 OF 36 REFERENCES
    HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine.
    • 46
    HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol.
    • S. Hung, Wen-Hung Chung, +16 authors Y. Chen
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 2005
    • 707
    • PDF
    Mechanisms of Idiosyncratic Hypersensitivity Reactions to Antiepileptic Drugs
    • 142
    Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity.
    • 82
    TNFα promoter region gene polymorphisms in carbamazepine-hypersensitive patients
    • 126
    Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones.
    • 197
    • PDF
    Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant
    • A. Martin, D. Nolan, +9 authors S. Mallal
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 2004
    • 422
    • PDF
    Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions.
    • 134
    Clinical heterogeneity of drug hypersensitivity.
    • 363
    Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study
    • 230